A new diabetes medicine is reported to slash chances of other ailments such as CV disease and kidney problems.
The experts have discovered several benefits to the glucose-lowering drug liraglutide. For one thing it lowers the chances of cardiac arrest, stroke and CV disease. All this is for people with type 2 diabetes.
We all know that CV disease is the #1 killer of people with type 2 diabetes. Liraglutide also decreases any chances of contracting kidney disease. It generally wards off all other afflictions and has been called a wonder drug.
The study was published in the New England Journal of Medicine. This study details findings from a global clinical trial called "Liraglutide Effect and Action in Diabetes Evaluation of Cardiovascular Outcome Results" or LEADER.
Over 700 institutes in 32 nations around the world engaged in extensive research on this drug. Their efforts prove that it is a miracle in the making. No other diabates drug has such a large amount of benefits for mankind.
One of the authors of the study mentioned that he had been excited about liraglutide since a long time ago. He knew that this was a unique drug. It even has an ameliorating effect on atherosclerosis. Atherosclerosis is the leading cause of heart attack and stroke.
"I've been excited about liraglutide for a long time because I think it's unique," said John Buse, MD, PhD, senior author of the study, director of the UNC Diabetes Care Center, and the Verne S. Caviness Distinguished Professor of Medicine at the UNC School of Medicine.
"This is the first diabetes drug that has shown across-the-board benefits for cardiovascular diseases, and this suggests it plays a role in treating atherosclerosis, which is what leads to heart attacks and strokes."
The study involved 9340 adults who had type 2 diabetes. They were at a great risk of getting a heart attack. Half were given liraglutide while half received a dummy pill (placebo).
The placebo group took other medications for their diabetes. Such ailments as hypertension and high cholesterol levels were also ameliorated via certain drugs in the group. The study tracked the patients for three years.
Liraglutide caused among other things, a 13% lower chance of dying from a heart attack, stroke or CV disease. It reduced deaths by CV causes by 22%. All causes of deaths were reduced by 15%. In particular, all signs of kidney disease were wiped out in 22% of the patients.
Such evidence is a game changer in the diabetes stakes. Up until now the drugs for diabetes were merely meant to treat the disease. Yet now it appears to be the case that the ten thousand other maladies that accompany diabetes will also get treated by this drug called liraglutide.
One other diabetes drug empagliflozin reduced chances of contracting CV disease. However, it was ineffective on other markers of disease. Liraglutide though worked across the board. Liraglutide also happens to decrease appetite.
How To: Buy a Pokemon Go Plus
Scientists are now looking forward to combining different doses of liraglutide and empagliflozin in order to treat diabetes and the many nasty side effects it causes.